Generic Drug Application Yields Patent Complaint In Delaware Federal Court

(January 22, 2021, 10:44 AM EST) -- WILMINGTON, Del. — Amgen Inc., maker of the chronic heart failure (CHF) drug Corlanor, levied allegations of patent infringement against the filers of an abbreviated new drug application (ANDA) in a complaint filed Jan. 20 in Delaware federal court....